One mandate. Different responsibilities.
Your office makes the investment decisions. Drovix provides an institutional liquidity relationship, supported by its own market-making and bridge technology. Explore what each side needs to understand.
The role map
The office sets the mandate.
The counterparty has a defined role.
Select a role to see what it owns, the information it needs and where Drovix fits.
Principal / Responsibility
What is the office authorising?
Decide the investment mandate and who may act for the office. Execution access does not transfer investment decisions to Drovix.
- Information to review
- Contracting entity, approved purpose, permitted instruments and authority to delegate.
- Drovix’s role
- The institutional counterparty relationship is defined through eligibility review and the client agreement—not by the investment mandate alone.
Behind the execution relationship
Drovix develops its own market-making and bridge technology. For the office, the important connection is between access to that liquidity and an agreed framework for instructions, risk and reporting.
Explore institutional liquidityContinue the review
Documents for the office
These public references explain the framework. Confirm the terms and technical scope applicable to your arrangement with the desk.
Talk to the institutional desk
Define the execution relationship.
Discuss the office’s dealing authority, execution scope and reporting needs with Drovix.
Contact DrovixLeveraged OTC products, including Forex and CFDs, carry a high level of risk and a counterparty may lose more than its initial margin. The Drovix offering is directed exclusively at Eligible Counterparties and Professional Clients; Drovix does not provide services to retail clients. Content on this page is factual and descriptive only and does not constitute investment advice, a recommendation, or an offer or solicitation to transact.
Drovix acts as principal in bilateral OTC transactions with approved institutional counterparties. It is not a public exchange, MTF, OTF or ECN. Services are not offered to retail clients or in jurisdictions where Drovix is not authorised or permitted to provide them. Instrument access, connectivity, risk parameters and commercial terms are subject to review and the signed institutional services agreement.